Key result
Pathologic high-frequency oscillations are promising biologic markers that may optimize surgical treatment and development of new therapies for medically refractory epilepsy.
Answers are grounded in this paper and cite their sources.
Pathologic high-frequency oscillations may serve as useful biomarkers in the surgical and medical management of epilepsy.
Summary Pathologic high‐frequency oscillations, believed to reflect basic neuronal disturbances responsible for epilepsy, are promising biologic markers that may be used in clinical studies to optimize surgical treatment of medically refractory epilepsy, and studies that seek to develop new therapies for treatment, and possible prevention, of epilepsy. For an expanded treatment of this topic see Jasper’s Basic Mechanisms of the Epilepsies, Fourth Edition (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado‐Escueta AV, eds) published by Oxford University Press (available on the National Library of Medicine Bookshelf [NCBI] at http://www.ncbi.nlm.nih.gov/books ).
No takes yet. Share an insight, caveat, or question.
Richard J. Staba (2010) conducted a review in epilepsy. Pathologic high-frequency oscillations was evaluated. Pathologic high-frequency oscillations are promising biologic markers that may optimize surgical treatment and development of new therapies for medically refractory epilepsy.
Synapse has enriched 10 related papers. Consider them for comparative context: